Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme
暂无分享,去创建一个
C. Cobbs | R. Kaslow | R. Miike | M. Wrensch | J. Wiencke | Jianming Tang | M. Dorak | W. Shao | E. Lobashevsky | Yufeng Li
[1] M. Torres,et al. Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.
[2] Sue Povey,et al. Gene map of the extended human MHC , 2004, Nature Reviews Genetics.
[3] C. Cobbs,et al. Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification. , 2004, Tissue antigens.
[4] K. Hess,et al. Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma , 2004, Clinical Cancer Research.
[5] K. Aldape,et al. Glutathione-S-transferase variants and adult glioma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[6] R. Weil,et al. A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease , 2004, Cancer Research.
[7] Y. Taketani,et al. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer , 2003, International journal of cancer.
[8] W. Klitz,et al. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. , 2003, Tissue antigens.
[9] A. Ahlbom,et al. Cohort studies of association between self‐reported allergic conditions, immune‐related diagnoses and glioma and meningioma risk , 2003, International journal of cancer.
[10] H. Grönberg,et al. Familial brain tumours—genetics or environment? A nationwide cohort study of cancer risk in spouses and first‐degree relatives of brain tumour patients , 2003, International journal of cancer.
[11] J. Hansen,et al. Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. , 2003, Tissue antigens.
[12] Geetha Krishnan,et al. Occupation and Adult Gliomas in the San Francisco Bay Area , 2003, Journal of occupational and environmental medicine.
[13] M. Tommasino,et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.
[14] Margaret Wrensch,et al. Molecular epidemiology of glioblastoma. , 2003, Cancer journal.
[15] W. Klitz,et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. , 2002, Journal of the National Cancer Institute.
[16] Effie W Petersdorf,et al. Nomenclature for factors of the HLA system, 2002. , 2002, Human immunology.
[17] Kirby I Bland,et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer , 2002, The Lancet.
[18] A. Hildesheim,et al. Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.
[19] M. Berger,et al. Epidemiology of primary brain tumors: current concepts and review of the literature. , 2002, Neuro-oncology.
[20] Douglas C. Miller,et al. Identification of Glutathione S-transferase (GST) Polymorphisms in Brain Tumors and Association with Susceptibility to Pediatric Astrocytomas , 2002, Journal of Neuro-Oncology.
[21] J. Kere,et al. A novel low-penetrance locus for familial glioma at 15q23-q26.3. , 2002, Cancer research.
[22] C. Cobbs,et al. Human cytomegalovirus infection and expression in human malignant glioma. , 2002, Cancer research.
[23] H. Fine,et al. History of allergies and autoimmune diseases and risk of brain tumors in adults , 2002, International journal of cancer.
[24] R. Miike,et al. History of allergies among adults with glioma and controls , 2002, International journal of cancer.
[25] J. Isola,et al. Cancer incidence in families with multiple glioma patients , 2002, International journal of cancer.
[26] G. Voglino,et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes , 2001, International journal of cancer.
[27] K. Cao,et al. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. , 2001, Human immunology.
[28] K. Aldape,et al. Ethnicity delineates different genetic pathways in malignant glioma. , 2001, Cancer research.
[29] N. Rainov,et al. Brain Glioma and Human Leukocyte Antigens (HLA) – is There an Association , 2001, Journal of Neuro-Oncology.
[30] S. H. van der Burg,et al. Natural T‐helper immunity against human papillomavirus type 16 (hpv16) e7–derived peptide epitopes in patients with hpv16‐positive cervical lesions: Identification of 3 human leukocyte antigen class ii–restricted epitopes , 2001, International journal of cancer.
[31] C. Amos,et al. Segregation analysis of cancer in families of glioma patients , 2001, Genetic epidemiology.
[32] H. Grönberg,et al. Genetic epidemiology of glioma , 2001, British Journal of Cancer.
[33] E. Karita,et al. Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women , 2000, Experimental and Clinical Immunogenetics.
[34] K. Aldape,et al. Association of an ERCC1 polymorphism with adult-onset glioma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[36] D. Middleton,et al. Genetic association studies of tumour necrosis factor α and β and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis , 1999, Journal of Neurology.
[37] G. Giles,et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study , 1999, International journal of cancer.
[38] M. Berger,et al. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. , 1999, Neuro-oncology.
[39] A. Silvani,et al. Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients. , 1999, Cancer genetics and cytogenetics.
[40] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[41] J. Bruner,et al. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[42] K. Kelsey,et al. A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. , 1997, Pharmacogenetics.
[43] K. Kelsey,et al. Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. , 1997, Carcinogenesis.
[44] R Miike,et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.
[45] G. Swanson,et al. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[46] F. Rousset,et al. AN EXACT TEST FOR POPULATION DIFFERENTIATION , 1995, Evolution; international journal of organic evolution.
[47] W. Klitz,et al. HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificity , 1994, Nature Genetics.
[48] J. Ragoussis,et al. Map of the human MHC. , 1991, Immunology today.
[49] M. Wrensch,et al. Genetics of primary brain tumors: a review , 2005, Journal of Neuro-Oncology.
[50] G. Giles,et al. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours , 2005, International journal of cancer.
[51] Kiyoshi Sato,et al. Association of malignant glioma with the human leukocyte antigen, HLA-A24(9) , 2004, Neurosurgical review.
[52] P. Black,et al. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[53] T. West,et al. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. , 2002, Clinical otolaryngology and allied sciences.
[54] J. Bruner,et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. , 1999, Neuro-oncology.
[55] J. Bruner,et al. Genetic Polymorphisms in Glutathione S-Transferaset and 0, N-Acetyltransferase, and CYPJA1 and Risk of Gliomas' , 1998 .
[56] M. Linet,et al. Etiology of brain tumors in adults. , 1995, Epidemiologic reviews.
[57] J. Ragoussis,et al. Map of the human MHC. , 1991, Immunology today.